These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 28290112)

  • 1. Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.
    Zhang Y; Milojevic D
    Paediatr Drugs; 2017 Jun; 19(3):193-211. PubMed ID: 28290112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.
    Soybilgic A; Tesher M; Wagner-Weiner L; Onel KB
    Pediatr Rheumatol Online J; 2014; 12():24. PubMed ID: 25053923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone health in pediatric rheumatic disease.
    Rouster-Stevens KA; Klein-Gitelman MS
    Curr Opin Pediatr; 2005 Dec; 17(6):703-8. PubMed ID: 16282774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
    Furia FF; Godfrey E; Mwamanenge N; Swai P
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):30. PubMed ID: 32245494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.
    LeBlanc CM; Ma J; Taljaard M; Roth J; Scuccimarri R; Miettunen P; Lang B; Huber AM; Houghton K; Jaremko JL; Ho J; Shenouda N; Matzinger MA; Lentle B; Stein R; Sbrocchi AM; Oen K; Rodd C; Jurencak R; Cummings EA; Couch R; Cabral DA; Atkinson S; Alos N; Rauch F; Siminoski K; Ward LM;
    J Bone Miner Res; 2015 Sep; 30(9):1667-75. PubMed ID: 25801315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise.
    Alsufyani KA; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Nadel H; Malleson PN
    J Rheumatol; 2005 Apr; 32(4):729-33. PubMed ID: 15801032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: A review of current literature.
    Huber AM; Ward LM
    Semin Arthritis Rheum; 2016 Aug; 46(1):49-63. PubMed ID: 27020068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
    Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids.
    Harrington J; Holmyard D; Silverman E; Sochett E; Grynpas M
    Pediatr Rheumatol Online J; 2016 Nov; 14(1):58. PubMed ID: 27832795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study.
    Rodd C; Lang B; Ramsay T; Alos N; Huber AM; Cabral DA; Scuccimarri R; Miettunen PM; Roth J; Atkinson SA; Couch R; Cummings EA; Dent PB; Ellsworth J; Hay J; Houghton K; Jurencak R; Larché M; LeBlanc C; Oen K; Saint-Cyr C; Stein R; Stephure D; Taback S; Lentle B; Matzinger M; Shenouda N; Moher D; Rauch F; Siminoski K; Ward LM;
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):122-31. PubMed ID: 22213727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone density in children and adolescents with rheumatic diseases. Preliminary results of selective measurement of trabecular and cortical bone using peripheral computerized tomography].
    Lettgen B; Neudorf U; Hosse R; Peters S; Reiners C
    Klin Padiatr; 1996; 208(3):114-7. PubMed ID: 8676598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of osteoporosis in rheumatoid arthritis patients.
    Hoes JN; Bultink IE; Lems WF
    Expert Opin Pharmacother; 2015 Mar; 16(4):559-71. PubMed ID: 25626121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
    Said MA; Silva LSTE; de Oliveira Rocha AM; Alves GGB; Piotto DGP; Len CA; Terreri MT
    Adv Rheumatol; 2020 Nov; 60(1):53. PubMed ID: 33153496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.
    von Scheven E; Corbin KJ; Stagi S; Cimaz R
    Curr Osteoporos Rep; 2014 Sep; 12(3):289-99. PubMed ID: 25001898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment].
    Di Munno O; Delle Sedie A
    Reumatismo; 2006; 58(1):11-21. PubMed ID: 16639483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fractures and bone mineral density in childhood].
    Hofmann C; Girschick H; Lapa C; Semler O; Jakob F
    Z Rheumatol; 2019 Sep; 78(7):636-644. PubMed ID: 31338681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture risk in systemic lupus erythematosus patients over 28 years.
    Garelick D; Pinto SM; Farinha F; Pires T; Khan E; Isenberg D
    Rheumatology (Oxford); 2021 Jun; 60(6):2765-2772. PubMed ID: 33221918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
    Rossini M; Viapiana O; Vitiello M; Malavolta N; La Montagna G; Maddali Bongi S; Di Munno O; Nuti R; Manzini CU; Ferri C; Bogliolo L; Mathieu A; Cantatore F; Del Puente A; Muratore M; Grassi W; Frediani B; Saviola G; Delvino P; Mirone L; Ferraccioli G; Tripi G; Piazza I; Gatti D
    Reumatismo; 2017 May; 69(1):30-39. PubMed ID: 28535619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary forms of osteoporosis. Special features of diagnostics in childhood and adolescence].
    Stark C; Hoyer-Kuhn H; Knoop K; Schoenau H; Schoenau E; Semler O
    Z Rheumatol; 2014 May; 73(4):335-41. PubMed ID: 24714928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.